Former President Donald Trump used a New York Post opinion piece to target the Biden administration on Friday night for allowing a break in Johnson & Johnson’s coronavirus vaccine, accusing him of allowing “bureaucrats who face insane risks to lead.” the show ”.
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) announced discontinuation of the vaccine Tuesday morning, citing six cases of women experiencing cerebral venous sinus thrombosis in combination with thrombocytopenia. cerebral blood clot.
On Friday night, the former president sent an e-mail repeating the arguments made by the editorial board of the New York Post, namely that the cases were rare enough not to prevent the launch of the vaccine, calling this movement “pure madness.”
“The federal break on the J&J shooting doesn’t make sense,” the statement said.
“Why does Biden’s White House leave bureaucrats with a risky madness to run the show? Only six of the nearly 7 million people who received the Johnson & Johnson vaccine reported blood clots, “the statement said.
The condition is more common in the general population, and each vaccine – indeed, each drug – carries a certain risk, including Modern and Pfizer jabs.
“With COVID cases on the rise nationwide, it is pure madness to delay millions of vaccinations and feed fears among those who resist vaguely. Indeed, this moronic movement is a gift to the anti-vax movement: the bureaucrats of science feed that disturbed pseudo-science. ”
While the break in the use of J&J photography was initially expected to last only a few days, the CDC Advisory Committee on Immunization Practices (ACIP) decided Wednesday that the break should remain in effect until the group meets again at 7 p.m. every 10 days.
The Biden administration defended the break, arguing that it is the right precaution to keep Americans safe.
“Science is moving at the speed of science and they want to review more data. We think I’m the gold standard, [Food and Drug Administration] The FDA is the world’s gold standard, “White House Secretary of State Jen Psaki said Thursday.
“In fact, their thorough and transparent approach should give the American public additional confidence in the role they play and in the approach the United States has taken to approving vaccines on the market.”
